Endocrine Therapy of Breast Cancer III edited by F. Cavalli.

The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Cavalli, F. (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1989.
Edition:1st ed. 1989.
Series:ESO Monographs, European School of Oncology
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.

MARC

LEADER 00000nam a22000005i 4500
001 b3213108
003 MWH
005 20191024221531.0
007 cr nn 008mamaa
008 121227s1989 gw | s |||| 0|eng d
020 |a 9783642745041 
024 7 |a 10.1007/978-3-642-74504-1  |2 doi 
035 |a (DE-He213)978-3-642-74504-1 
050 4 |a E-Book 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
245 1 0 |a Endocrine Therapy of Breast Cancer III  |h [electronic resource] /  |c edited by F. Cavalli. 
250 |a 1st ed. 1989. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 1989. 
300 |a VII, 65 p. 4 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a ESO Monographs, European School of Oncology 
490 1 |a Springer eBook Collection 
505 0 |a Progression from Steroid Responsive to Unresponsive State in Breast Cancer -- Drug Resistance -- Integration of Quality-of-Life Issues into Clinical Trials of Breast Cancer -- Adjuvant Systemic Therapy for Breast Cancer Patients Without Lymph Node Metastases (N-) -- New Developments in the Field of Aromatase Inhibitors -- Resistance to Antioestrogen Therapy: a Challenge for the Future -- New Antioestrogens Without Oestrogenic Activity. 
520 |a The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli­ nary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of on­ cology. 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
650 0 |a Oncology  . 
650 0 |a Endocrinology . 
650 0 |a Gynecology . 
650 0 |a Radiotherapy. 
690 |a Electronic resources (E-books) 
700 1 |a Cavalli, F.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
830 0 |a ESO Monographs, European School of Oncology 
830 0 |a Springer eBook Collection. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-3-642-74504-1  |3 Click to view e-book 
907 |a .b32131082  |b 04-18-22  |c 02-26-20 
998 |a he  |b 02-26-20  |c m  |d @   |e -  |f eng  |g gw   |h 0  |i 1 
912 |a ZDB-2-SME 
912 |a ZDB-2-BAE 
950 |a Medicine (Springer-11650) 
902 |a springer purchased ebooks 
903 |a SEB-COLL 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i21262731  |z 02-26-20 
999 f f |i b57c1992-253a-50bc-8333-cedcb2f799bc  |s 28753c6d-de16-55ae-9038-f924eef1347f 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d Online  |e E-Book  |h Library of Congress classification  |i Elec File  |n 1